TB-500 Peptide: Research, Side Effects, Legal Status & Cost
TB-500: the quick answer
What it is
TB-500 is a synthetic peptide based on an active fragment of thymosin beta-4, a natural protein involved in cell movement and tissue repair.
Evidence level
Animal and laboratory studies. There are no completed human efficacy trials.
Status
Not an approved medicine in the US or UK. In the US, HHS has said it does not intend to take enforcement action against state-licensed pharmacies that compound TB-500 on its own, for subcutaneous or intramuscular injection, on a patient-specific prescription. This is interim enforcement discretion, not FDA approval.
This page is informational and does not diagnose, prescribe, or recommend therapies.
What is TB-500?
TB-500 is a lab-made peptide modeled on an active fragment of thymosin beta-4, a protein the body produces naturally. It is usually described as the seven-amino-acid sequence Ac-LKKTETQ, residues 17 to 23 of thymosin beta-4. Thymosin beta-4 helps regulate actin, one of the building blocks of cells, and is involved in cell migration (how cells move) and in tissue repair. TB-500 is the synthetic fragment, not the whole protein, so studies of full-length thymosin beta-4, including human trials in eye and skin conditions, are about a different, larger molecule and are not evidence for TB-500.
The name causes real confusion. TB-500 is related to thymosin beta-4, not to thymosin alpha-1, a different, immune-related peptide that is an approved medicine (as Zadaxin) in more than 35 countries. The difference matters in sport: TB-500 is prohibited by WADA, while thymosin alpha-1 is not named on the prohibited list.
How TB-500 is thought to work comes from thymosin beta-4's role in actin regulation, cell movement and repair. Most of what is described about it comes from animal and laboratory research rather than human trials, so a mechanism should not be read as a proven clinical result.
TB-500 is most often discussed next to BPC-157, as part of recovery and soft-tissue programs. The two are different peptides from different sources, and under the US policy each may be compounded only on its own.
What TB-500 is used for
Recovery and rehabilitation discussions, usually framed around soft-tissue repair and often paired with BPC-157.
Performance-oriented provider listings, where the WADA prohibition is the first thing an athlete needs to know.
Longevity or regenerative settings, as one element of a broader, clinician-led plan rather than a standalone fix.
US compounding on prescription, by subcutaneous or intramuscular injection only, within the interim HHS policy (see legal status below).
The claims people most often search for about TB-500, set against the research. The evidence level names the kind of study a claim rests on: cell (laboratory) studies, animal studies, human studies, or none. Educational only, not medical advice.
Overall: Preclinical only, based on animal and laboratory research. There are no completed human efficacy trials. Human data: Insufficient. No completed human efficacy trials.
Claim
Evidence level
What the evidence shows
“Speeds up healing of muscle, tendon and ligament injuries”
Animal
Animal and laboratory studies of tissue repair underpin this claim. There are no completed human efficacy trials, so faster healing in people has not been shown.
“Works better stacked with BPC-157”
None
No completed human trial has tested the combination. A vial that blends BPC-157 and TB-500 (sometimes sold as 'Wolverine') has two active ingredients, so it is outside the US policy, which covers each peptide only on its own.
“The recovery peptide athletes use”
Banned in sport
TB-500 is prohibited at all times by WADA. Strict liability applies to athletes, whatever it is marketed for.
“The same thing as thymosin alpha-1”
Different molecule
TB-500 is a fragment of thymosin beta-4. Thymosin alpha-1 is a separate immune-related peptide with its own approvals abroad. Treating them as one confuses both the evidence and the anti-doping position.
“Pharma-grade and clinically proven”
No approval
No regulator has approved TB-500 and there is no completed human efficacy trial. 'Research use only' product is not independently verified for identity or purity.
TB-500 side effects and risks
What is known
No side-effect profile has been established for TB-500 in people. Without completed human efficacy trials, its long-term safety in humans has not been established through large clinical trials either.
What is not known
There is no established dosing, no adverse-event profile from controlled human studies and no long-term data. What is described online about how it is tolerated is not drawn from those.
Product quality and gray-market vials
Outside the US prescription route, TB-500 is sold mainly by research-chemical suppliers, and product quality varies across an unregulated supply chain. A product compounded on prescription under the US policy has to meet its quality conditions; a 'research use only' vial meets none of them. The policy's conditions are under legal status.
Who should take particular care
Tested athletes. TB-500 is prohibited at all times, and strict liability means a positive test is a violation whatever the reason.
Anyone offered a BPC-157 and TB-500 blend. It is outside the US policy because it has two active ingredients.
Anyone buying 'research use only' vials, for the quality reasons above.
TB-500 dosage: why this page gives no dose
There is no approved dose of TB-500: no regulator has approved it, and no completed human efficacy trial has established one. Under the US policy, a compounded TB-500 product (subcutaneous or intramuscular injection) is made for one named patient on a prescription, so the amount and schedule are set by the prescriber.
TB-500 is usually quoted in milligrams rather than micrograms, which is where most arithmetic errors with these vials come from. That is a units problem, not a dose recommendation.
Peptide Clinic Finder does not give doses, and this page has no dosing chart. If you have been prescribed it, the amount, form and schedule are the prescriber's and the pharmacy's instructions, not a figure from a website.
TB-500 dosage calculator: Converts a prescribed amount into concentration, volume and U-100 syringe units, with mg and mcg side by side. Arithmetic only: it does not suggest an amount.
peptide calculator: The same arithmetic for any reconstituted vial, with a full reconstitution chart.
Is TB-500 legal? US, UK and sport status
United States
Not FDA-approved and with no completed human efficacy trials, making it an unapproved, investigational substance. Under the HHS interim policy announced on October 28, 2026 and published in the Federal Register on October 30, 2026, state-licensed pharmacies, federal facilities and licensed physicians may compound it for an individual prescription, as the only active ingredient, for subcutaneous or intramuscular injection, if the policy's conditions are met. Interim enforcement discretion, not approval (checked October 30, 2026).
What the policy requires: for TB-500, the covered form is TB-500, as a subcutaneous or intramuscular injection compounded from the bulk ingredient. The other conditions in Appendix B are the same for all six peptides it lists: a licensed clinician prescribes it for an individual patient; a state-licensed pharmacy compounds it from bulk ingredient made by an FDA-registered, CGMP manufacturer with a certificate of analysis; the product contains no other active ingredient; the label says it is a compounded drug product, not for resale; and serious adverse events are reported to FDA's MedWatch and to the states involved. The policy does not cover 503B outsourcing facilities, “research use only” products or dietary supplements. Our guide to the October 2026 US peptide policy sets out each condition and its source.
The same interim policy covers five other peptides, each only on its own and by its own route: KPV peptide (covered for topical or oral use only), Semax peptide (covered for intranasal use only), Epitalon peptide (covered by subcutaneous or intramuscular injection, dispensed in intermittent courses), BPC-157 peptide (covered by subcutaneous or intramuscular injection, by mouth or on the skin) and MOTS-c peptide (covered by subcutaneous or intramuscular injection).
United Kingdom
Not a licensed UK medicine. No current UK marketing authorization was found for TB-500 in the MHRA Products register. The HHS policy is US only and changes nothing in the UK or Ireland.
Last reviewed October 30, 2026. Regulatory status can change. Always confirm the current position with a qualified clinician.
Questions to ask a prescriber or clinic about TB-500
How do you decide between TB-500, BPC-157, or simpler alternatives?
What safety monitoring and review are included?
How should I think about evidence quality and expectations?
What a credible provider tells you
A credible clinic should be clear that TB-500 is not a licensed medicine, that evidence is largely preclinical, and that it is banned in tested sport.
Expect a proper assessment of your history and goals, plus a clear explanation of sourcing, supervision, and follow-up before any protocol is discussed.
Be cautious if a provider presents TB-500 as low-risk or outcome-guaranteed, or cannot explain its regulatory status.
Red flags
Clinics presenting TB-500 as low-risk or outcome-guaranteed.
No discussion of evidence limits, regulatory status, or the WADA ban.
No clear follow-up plan.
TB-500 cost and US availability
TB-500 is rarely a standalone priced item in clinics; it is usually folded into a wider recovery or regenerative program, sometimes combined with BPC-157. In the US, since the October 2026 HHS interim policy, some telehealth services price a compounded single-ingredient TB-500 per month, if prescribed; a BPC-157 and TB-500 blend is outside that policy. Clinician involvement, monitoring, and sourcing transparency remain more meaningful comparison points than the headline figure. See the peptide therapy cost guide. For US readers, what the October 2026 HHS policy changed for this peptide and its common pairing is in our US guide to TB-500 and BPC-157 prescriptions.
US telehealth prices for compounded TB-500 are shown to US visitors. It is not a licensed medicine in the UK.
Frequently asked questions about TB-500
What is TB-500 used for?
TB-500 is referenced mainly in recovery and soft-tissue repair contexts, often paired with BPC-157, and in performance and regenerative settings. Those uses rest on animal and laboratory studies; there are no completed human efficacy trials.
Is TB-500 safe?
That has not been established. With no completed human efficacy trials, there is no established side-effect profile and no long-term human safety data, and research-chemical product varies in quality. It is also banned in tested sport. Anyone considering it should do so only with a licensed clinician.
Is TB-500 legal in the US?
Yes, within limits. Under an interim HHS policy announced on October 28, 2026 (published in the Federal Register on October 30), HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities and licensed physicians that compound TB-500, as the only active ingredient, by subcutaneous or intramuscular injection for an individual prescription, if the policy's conditions are met. In practice a licensed US prescriber can order it for you from a state-licensed pharmacy. That is not FDA approval and HHS may revisit it. A BPC-157 and TB-500 blend and 'research use only' products are outside it, and TB-500 remains banned in tested sport.
Is TB-500 legal in the UK?
TB-500 is not licensed as a medicine in the UK; no current UK marketing authorization was found in the MHRA Products register.
Is TB-500 FDA-approved in the US?
No. TB-500 is not FDA-approved for any human use and has no completed human efficacy trials. Under an interim HHS policy announced on October 28, 2026 (published in the Federal Register on October 30), HHS does not intend to take enforcement action against state-licensed pharmacies, federal facilities and licensed physicians that compound it, as the only active ingredient, for subcutaneous or intramuscular injection on an individual prescription under set conditions; HHS says that is not approval and that it may revisit the policy. Outside that route it is sold mainly by research-chemical suppliers.
Is TB-500 banned in sport?
Yes. TB-500 is prohibited at all times by the World Anti-Doping Agency (WADA). Any athlete subject to drug testing should treat it as a banned substance.
Does TB-500 work?
Most research on TB-500 comes from animal and laboratory studies of tissue repair. There are no completed human efficacy trials, so whether it works in people is not established, and claims of proven benefits should be treated with caution.
Is TB-500 the same as thymosin alpha-1?
No. TB-500 is based on a fragment of thymosin beta-4. Thymosin alpha-1 is a different, immune-related peptide, approved as Zadaxin in more than 35 countries and not named on the WADA prohibited list, while TB-500 is prohibited at all times.
Is TB-500 the same as BPC-157?
No. TB-500 is based on a fragment of thymosin beta-4; BPC-157 is a 15-amino-acid sequence derived from a protein in gastric juice. Clinics often discuss them together in recovery contexts, and both rest mostly on animal research. Under the US policy each may be compounded only on its own, so a blend of the two is outside it. See our BPC-157 vs TB-500 comparison.
Does Peptide Clinic Finder sell or recommend TB-500?
No. Peptide Clinic Finder is an informational directory. We do not sell TB-500, provide medical advice, or recommend its use — we help you compare how clinics position and supervise treatments so you can make an informed decision with a licensed clinician.
If you are considering this treatment, compare providers, review your options, and choose the path that best fits your goals and preferred level of care.
Doctor-led peptide advisory consultations in central London. Every protocol is built around comprehensive bloodwork and personally led by Dr Ethan Hausman-Marquis, who reports a PhD from the Karolinska Institute, with compounds sourced from GMP-certified, EMA-regulated pharmacies.
The Forest Lounge Medical Center is a clinician-led peptide and longevity clinic in Lake Forest, Illinois. Care is delivered by licensed medical providers and covers peptide therapy, hormone optimization, metabolic health, recovery, performance and body composition, with plans based on individual goals, laboratory testing and ongoing monitoring.
Medical credentials✓
✓Physicians: Dr. Tarak Chokshi, MD and Dr. Richard Scuderi, MD, both listed in the federal NPI registry with Illinois medical license numbers on record.
LiveNow Longevity is a physician-led longevity and peptide clinic in Las Vegas — built on a simple promise: transparent medicine with no markup on your meds. Founded by board-certified neurologist Dr. Charles Kamen, MD, every patient starts with an $88 medical evaluation including baseline labs. From there, care can include peptide therapy, anti-aging treatments, GLP-1 weight loss (semaglutide and tirzepatide), NAD+ therapy, hormone optimization, and recovery support. In person in Las Vegas, or via telehealth across Nevada.
Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practice within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards.
The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence.
Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.
Harley Street Medical Doctors is a peptide clinic in London, UK. Its listed focus spans weight management and peptide therapy. It holds a 4.7-star Google rating from 49 reviews.
Move from treatment research into provider comparison by choosing the next step that fits your buying journey. Some users want to compare programs first, while others want a faster route into matched options or local clinic discovery.
Move from peptide research into real provider comparison by checking city pages, cost context, and related treatment comparisons. Clinics vary more by oversight and program structure than by peptide name alone.